Venus Medtech’s $300 Million Acquisition of Cardiovalve

Willkie Farr & Gallagher advised Cardiovalve in the transaction.Venus Medtech announced its acquisition of Cardiovalve Ltd. (f/k/a Mitraltech Ltd.), a transcatheter mitral and tricuspid valve treatment…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here